What must a reprocessor demonstrate to FDA to reprocess a Class II or Class III SUD?

Reprocessors must meet the same premarket requirements applicable to the device class, typically 510(k) clearance supported by validation data on cleaning efficacy, sterility assurance, and functional performance equivalent to the original device, per FDA's guidance on reprocessing validation methods and labeling. Higher-risk SUD categories face additional scrutiny, and FDA maintains a list of device types for which reprocessing exemptions have been terminated, requiring case-by-case clearance.

How much cost savings does reprocessing actually deliver, and does it affect clinical performance?

Properly validated reprocessed devices, such as EP catheters, harmonic scalpels, and orthopedic burrs, typically reduce device acquisition cost by 40 to 60 percent with no demonstrated difference in clinical performance when reprocessing follows FDA-cleared validation protocols. Performance risk arises specifically when reprocessing occurs outside FDA-cleared parameters or by unregistered reprocessors, which is why hospital value analysis committees should confirm a reprocessor's clearance status rather than assuming equivalence.

What non-clinical factors are driving adoption of single-use versus reprocessed devices?

Beyond cost, hospitals face increasing environmental and Joint Commission scrutiny of single-use device waste streams, which is pushing sustainability-minded health systems toward validated reprocessing programs as a formal part of supply chain and environmental, social, and governance strategy. Manufacturers designing new single-use products should anticipate this pressure and consider whether a design supports safe, validated reprocessing rather than assuming disposability is a permanent competitive advantage.

All terms

Market SegmentsGlobal Markets Strategic LandscapeSUD

Single-Use Device

A device the original manufacturer labels for one use or one patient, distinct from reusable devices and from FDA-regulated reprocessed SUDs.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

Definition

A Single-Use Device (SUD) is one whose original-equipment manufacturer (OEM) labeling restricts it to a single use or single patient. The Medical Device User Fee and Modernization Act (MDUFMA) of 2002 created a separate regulatory pathway for third-party reprocessors of SUDs: they must obtain their own 510(k) clearance and comply with the same cleaning, sterilization, and functional-equivalence validation as OEMs. SUDs and reprocessed SUDs are a major sustainability and cost-pressure topic in hospital purchasing.

What the regulation says

FDA Guidance: 'Reprocessed Single-Use Devices: Termination of Exemptions from Premarket Notification' and the 2018 final guidance on reprocessing validation. 21 USC 360e (PMA) and 510(k) requirements both apply depending on device class.

What this means in practice

Reprocessed SUDs typically cut device cost 40-60% with no clinical performance difference when properly validated. FDA has cleared reprocessed versions of EP catheters, harmonic scalpels, and orthopedic burrs.

Examples

A disposable surgical scalpel blade is a common single-use device, designed for one incision and then discarded to maintain sterility and sharpness.
Many types of catheters, such as urinary catheters or certain cardiovascular catheters, are labeled as single-use to prevent infection and ensure optimal performance for each patient.
Certain biopsy needles or arthroscopic shavers are single-use devices, intended for one procedure to guarantee sterility and integrity of the sharp edges or moving parts.

Common pitfalls

•Assuming OEM SUD labeling alone prevents a hospital from using a third-party reprocessor, it does not.
•Ignoring environmental and Joint Commission scrutiny of single-use waste streams.

Frequently asked questions

No. Under the regulatory framework established by the Medicare Device User Fee and Modernization Act of 2002, a third-party reprocessor may legally reprocess and resell a single-use device as long as the reprocessor obtains its own 510(k) clearance and validates cleaning, sterilization, and functional equivalence, regardless of the OEM's single-use labeling. This is one of the most common misconceptions in hospital purchasing: OEM labeling reflects the manufacturer's validation scope, not a legal barrier to reprocessing.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Market Segments

Endoscopy Devices

Flexible and rigid scopes plus accessories used for visualization, diagnosis, and therapy inside the GI tract, airways, urinary tract, and joints.

Regulatory

510(k) Premarket Notification(510(k))

FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.

Post-Market

Post-Market Surveillance(PMS)

Activities to monitor device safety and performance after market release.

More in Market Segments

· Same category

Market Segments

Aesthetic & Energy-Based Devices

Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.

Market Segments

AI Imaging Software

Software that analyzes medical images to triage, detect, or quantify disease.

Market Segments

Cardiac Rhythm Management(CRM)

Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.

Market Segments

Cardiovascular Devices

Devices for diagnosing, monitoring, or treating cardiovascular disease.

Cited by

Where this term appears across MedTech Terms.

Ecosystems (2)

Latest in MedTech

Sources

3 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 2Tier 4Trade press and expert commentary· 1

Link health: 3 verified· last checked 2026-06-20

FDA·2MedTech Dive·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Market Segments0 / 38

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Market Segments
Acronym: SUD
Sources: 3
Updated: 5/9/2026

Compare with another term

Learn in 60 seconds

A device the original manufacturer labels for one use or one patient, distinct from reusable devices and from FDA-regulated reprocessed SUDs.

·Reprocessed SUDs typically cut device cost 40-60% with no clinical performance difference when properly validated.
·FDA has cleared reprocessed versions of EP catheters, harmonic scalpels, and orthopedic burrs.
·SUDs and reprocessed SUDs are a major sustainability and cost-pressure topic in hospital purchasing.

Remember this

Watch out: Assuming OEM SUD labeling alone prevents a hospital from using a third-party reprocessor, it does not.

Related terms

You may also need

Auto-suggested from Market Segments and shared keywords.

All Market Segments terms